Per Eriksson Oliver Skoglund Cecilia Hemgren Christopher Sjöwall
10.3389/fimmu.2023.1187584
Front Immunol
2023 May 25;14:1187584.
janus kinase inhibitor (jaki) baricitinib corticosteroids giant cell (temporal) arteritis inflammation interleukin - 6 large vessel vasculitis therapy -
CC BY
https://pubmed.ncbi.nlm.nih.gov/37304255/
Arthritis Giant Cell Arteritis / drug therapy Janus Kinase Inhibitors / adverse effects
Arthritis Giant Cell Arteritis / drug therapy Janus Kinase Inhibitors / adverse effects Randomized Controlled Trial Clinical Trial, Phase III Research Support, Non-U.S. Gov't Humans Prednisolone Sweden Janus Kinase Inhibitors Prednisolone
PMC10247956
37304255
Clinical experience and safety of Janus kinase inhibitors in giant cell arteritis: a retrospective case series from Sweden
2023